Order Article Reprints

Zhou S, Obianom ON, Huang J, Guo D, Yang H, Li Q, Shu Y. RETRACTED: Pyrvinium Treatment Confers Hepatic Metabolic Benefits via β-Catenin Downregulation and AMPK Activation. Pharmaceutics. 2021; 13(3):330. https://doi.org/10.3390/pharmaceutics13030330

Zhou, Shiwei, Obinna N. Obianom, Jiangsheng Huang, Dong Guo, Hong Yang, Qing Li, and Yan Shu. 2021. "RETRACTED: Pyrvinium Treatment Confers Hepatic Metabolic Benefits via β-Catenin Downregulation and AMPK Activation" Pharmaceutics 13, no. 3: 330. https://doi.org/10.3390/pharmaceutics13030330

Zhou, S., Obianom, O. N., Huang, J., Guo, D., Yang, H., Li, Q., & Shu, Y. (2021). RETRACTED: Pyrvinium Treatment Confers Hepatic Metabolic Benefits via β-Catenin Downregulation and AMPK Activation. Pharmaceutics, 13(3), 330. https://doi.org/10.3390/pharmaceutics13030330